CUSIP 74065P101COMPRLDQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
47 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Orbimed Advisors LLC | 10.91M | $31.64M | 0 | Held |
| 2 | Baker Bros. Advisors LP | 10.12M | $29.36M | 0 | Held |
| 3 | Vanguard Group Inc | 1.41M | $4.10M | +421.1K | Added |
| 4 | Kynam Capital Management, LP | 788.9K | $2.29M |
| +788.9K |
| New |
| 5 | Two Sigma Investments, LP | 788.7K | $2.29M | +636.5K | Added |
| 6 | Morgan Stanley | 334.9K | $971.3K | +50.7K | Added |
| 7 | Marshall Wace, LLP | 273.9K | $794.3K | +273.9K | New |
| 8 | Geode Capital Management, LLC | 272.9K | $791.5K | +55.3K | Added |
| 9 | Renaissance Technologies LLC | 271.3K | $786.8K | −272.7K | Reduced |
| 10 | Blackrock, Inc. | 266.3K | $772.2K | +1.3K | Added |
See every fund holding Prelude Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders